June 1, 2020 / 3:26 AM / a month ago

BRIEF-Marksans Pharma Gets Communication From USFDA On Verification Of NDMA In Metformin Extended Release Tablets

June 1 (Reuters) - Marksans Pharma Ltd:

* GOT COMMUNICATION FROM USFDA ON VERIFICATION OF NDMA IN METFORMIN EXTENDED RELEASE TABLETS

* SUBMITTED PRELIMINARY RESPONSE TO USFDA, FURTHER COMMUNICATING WITH THEM

* FOR YEAR ENDED MARCH 31, EXPORTS TO USA FOR METFORMIN EXTENDED RELEASE TABLETS WAS LESS THAN 1% OF CONSOL REVENUE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below